HPLC Method Development and Validation for Simultaneous Estimation of Succinic Acid and Succinylmonocholine in Succinylcholine Chloride Injection
DOI:
https://doi.org/10.37591/rrjodfdp.v2i3.333Abstract
Succinylcholine chloride injection USP is a sterile, non-pyrogenic solution to be used as a short-acting, depolarizing, skeletal muscle relaxant. The injection is administered as IM or IV use. Succinylcholine chloride, USP is chemically designated C14H30N2O4 and its molecular weight is 290.399. Succinylcholine chloride has three known impurities: (1) Doublet peak, (2) Succinic acid and (3) Succinylmonocholine chloride. Out of these impurities, succinic acid and succinylmonocholine chloride are degradation impurities, whereas doublet peak is process related impurity. These impurities are controlled in succinylcholine chloride injection. Hence, an analytical method for simultaneous estimation of succinic acid and succinylmonocholine chloride in succinylcholine chloride injection is developed and validated. In this method, succinic acid and succinylmonocholine chloride were found to be specific, linear and robust. The method is also stability indicating as evidenced by forced degradation studies. Hence, this method can be used for routine analysis.
Keywords: Succinylcholine chloride injection, degradation products, HPLC
Cite this Article
Subrahmanya Bhat K, Puranik SB, Mahabaleshwara K. HPLC method development and validation for simultaneous estimation of succinic acid and succinylmonocholine in succinylcholine chloride injection. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2015; 2(3): 52–60p
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |